Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Author's Takes
  • Reviews
    • View all reviews ...
    • Aging (Jul 2022)
    • Next-Generation Sequencing in Medicine (Jun 2022)
    • New Therapeutic Targets in Cardiovascular Diseases (Mar 2022)
    • Immunometabolism (Jan 2022)
    • Circadian Rhythm (Oct 2021)
    • Gut-Brain Axis (Jul 2021)
    • Tumor Microenvironment (Mar 2021)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Commentaries
    • Concise Communication
    • Editorials
    • Viewpoint
    • Top read articles
  • Clinical Medicine
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Author's Takes
  • In-Press Preview
  • Commentaries
  • Concise Communication
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact

JCI Editorial Board
potential first-tier conflicts of interest

Updated May 11, 2022

Go to the JCI's conflict-of-interest policy

 

AbbVie (A.B. Heimberger)

AccureX (D. Krainc)

Actuate Therapeutics (S.A. Abdulkadir)

Arvinas (M. Hussain)

Astellas Pharma (S.A, Abdulkadir)

AstraZeneca (M. Hussain)

Bayer (M. Hussain)

Boehringer Ingelheim (G.D. Barish)

Caris Life Sciences (A.B. Heimberger)

Celularity (A.B. Heimberger)

Codiak (A.B. Heimberger)

Genentech (M. Hussain)

Google (J. Choi)

Inomagen Therapeutics Inc. (R. Arora)

Intellia Therapeutics (D. Krainc)

Ionis (J. Bass)

Intellia Therapeutics (D. Krainc)

Mannin Research Inc. (S.E. Quaggin)

Medtronic (J. Bass)

Merck (A.B. Heimberger)

Nfold (S. Eisenbarth)

OrbiMed Advisors (D. Krainc)

Parexel (S. Bulun)

Pfizer (N.S. Chandel)

Praxis Precision Medicines (A.L. George Jr.)

Rafael Pharmaceuticals (N.S. Chandel)

Regeneron (J. Bass)

Roche (S.E. Quaggin)

Tevard Biosciences (A.L. George Jr.)

Thermo Fisher Scientific (J. Bass)

Vertex (J. Bass)

Vortex Biosciences (S.A, Abdulkadir)

WCG (A.B. Heimberger)

Yumanity Therapeutics (A.B. Heimberger)

Vanqua Bio (D. Krainc)

 

Advertisement

Copyright © 2022 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts